Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113M | $130M | $151M | $210M | $187M | $259M | $277M | $285M | $256M | $212M |
| Revenue growth | — | 15.6% | 15.6% | 39.6% | -11.2% | 38.5% | 7.1% | 3.0% | -10.4% | -16.9% |
| Operating income | -$56.2M | -$17.1M | -$40.9M | -$17.3M | -$53.9M | -$123M | -$458M | -$136M | -$195M | -$102M |
| Operating margin | -49.8% | -13.1% | -27.2% | -8.2% | -28.9% | -47.4% | -165.2% | -47.5% | -76.5% | -48.0% |
| Net income | -$75.7M | -$19.6M | -$53.0M | -$17.1M | -$55.4M | -$129M | -$465M | -$135M | -$189M | -$103M |
| Net margin | -67.1% | -15.1% | -35.2% | -8.1% | -29.7% | -49.7% | -167.9% | -47.2% | -74.1% | -48.7% |
| EPS (diluted) | -$32.48 | -$7.86 | -$2.79 | -$0.72 | -$2.04 | -$3.99 | -$13.92 | -$3.69 | -$3.91 | -$1.95 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$32.5M | -$22.1M | -$19.0M | $11.5M | -$7.60M | -$38.5M | -$53.9M | -$185K | -$8.82M | $9.29M |
| Capital expenditures | $1.83M | $1.22M | $5.92M | $8.28M | $5.41M | $3.11M | $1.17M | $667K | $1.56M | $480K |
| Free cash flow | -$34.3M | -$23.3M | -$24.9M | $3.18M | -$13.0M | -$41.6M | -$55.1M | -$852K | -$10.4M | $8.81M |
| Share buybacks | — | — | — | — | $0.00 | $0.00 | $40.0M | $0.00 | $0.00 | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $22.8M | $21.3M | $39.6M | $104M | $293M | $233M | $122M | $91.8M | $65.6M | $48.7M |
| Total assets | — | $101M | $154M | $224M | $423M | $1.26B | $691M | $574M | $393M | $286M |
| Total liabilities | — | — | — | $81.0M | $265M | $573M | $480M | $439M | $323M | $292M |
| Long-term debt | — | $57.0M | $46.7M | $13.0K | $174M | $184M | $226M | — | $219M | $213M |
| Shareholders' equity | -$217M | -$209M | $52.0M | $143M | $157M | $691M | $212M | $135M | $70.0M | -$6.51M |
| Retained earnings | — | -$268M | -$321M | -$339M | -$394M | -$523M | -$977M | -$1.11B | -$1.30B | -$1.40B |
| Shares (wtd avg diluted) | — | 3.44M | 22.5M | — | 27.2M | 32.2M | 33.4M | 36.5M | 48.4M | 53.1M |
Every figure is extracted from Cardlytics, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.